Literature DB >> 12403724

Drug marketing: unsafe at any dose?

.   

Abstract

Mesh：

Year:  2002        PMID： 12403724      PMCID： PMC134161     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma?

Authors:  Catherine Lemière; Allan Becker; Louis-Philippe Boulet; Dennis Bowie; André Cartier; Donald Cockroft; Robert Cowie; Pierre Ernst; Mark Fitzgerald; Malcolm Sears; Sheldon Spier
Journal:  CMAJ       Date:  2002-10-29       Impact factor: 8.262

Review 2.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262
  2 in total
  2 in total

1.  Drug marketing priorities.

Authors:  Allan Abbass
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

2.  Mandatory pharmacovigilance.

Authors:  Walter P Maksymowych
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.